21:10:59 EST Thu 19 Nov 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Bausch Health Companies Inc
Symbol BHC
Shares Issued 374,397,389
Close 2026-11-19 C$ 12.30
Market Cap C$ 4,605,087,885
Recent Sedar+ Documents

Bausch Health's Solta Medical reaches 10M treatments

2026-11-19 19:28 ET - News Release

Mr. Thomas Appio reports

BAUSCH HEALTH'S AESTHETIC BUSINESS, SOLTA MEDICAL, SURPASSES 10 MILLION TREATMENTS WORLDWIDE

Bausch Health Companies Inc.'s Solta Medical, a global leader in the medical aesthetics market, has surpassed 10 million treatments worldwide across its aesthetic technology portfolio, marking a significant milestone in the company's history.

As the manufacturer of leading aesthetic technologies, including Thermage, Fraxel, Clear + Brilliant Touch and VASERlipo, Solta Medical has helped advance medical aesthetics through science-driven innovation. Its portfolio spans non-invasive skin tightening, laser skin resurfacing and rejuvenation, and minimally invasive body contouring, providing health care providers with a range of technologies to address diverse patient needs.

Reaching 10 million treatments worldwide underscores the continued global adoption of Solta Medical's technologies and the company's enduring leadership in the evolving aesthetics market. The portfolio milestone is further reinforced by Thermage surpassing seven million tips globally, demonstrating the lasting strength and continued importance of Solta Medical's flagship brand.

"Surpassing 10 million tips sold worldwide is a significant achievement for Solta Medical and reflects the continued confidence and trust health care providers and consumers place in our technologies," said Jiny Kim, senior vice-president, Solta Medical, Bausch Health. "As consumer needs and expectations evolve, our commitment is to build on that trust through continued clinical differentiation and meaningful innovation."

"This milestone demonstrates the strength of Solta Medical's brands and the global reach of its portfolio," said Thomas J. Appio, chief executive officer, Bausch Health. "Solta Medical is a key part of Bausch Health's long-term strategy, and we are focused on building upon its established global presence and supporting its continued growth."

About Bausch Health Companies Inc.

Bausch Health is a global, diversified pharmaceutical company enriching lives through its relentless drive to deliver better health care outcomes. It develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through its controlling interest in Bausch + Lomb. Its ambition is to be a globally integrated health care company, trusted and valued by patients, HCPs, employees and investors. Its aesthetic business, Solta Medical, is a global leader in the aesthetics market, whose vision is to develop and support trusted aesthetic brands that provide value to its customers and patients.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.